Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Entero Healthcare Solutions IPO is a book build issue of ₹1,600.00 crores. The issue is a combination of fresh issue of 0.80 crore shares aggregating to ₹1,000.31 crores and offer for sale of 0.48 crore shares aggregating to ₹599.69 crores.
Entero Healthcare Solutions IPO bidding started from Feb 9, 2024 and ended on Feb 13, 2024. The allotment for Entero Healthcare Solutions IPO was finalized on Feb 14, 2024. The shares got listed on BSE, NSE on Feb 16, 2024.
Entero Healthcare Solutions IPO price band is set at ₹1258.00 per share . The lot size for an application is 11. The minimum amount of investment required by an retail is ₹13,145 (11 shares). The lot size investment for sNII is 15 lots (165 shares), amounting to ₹2,07,570, and for bNII, it is 73 lots (803 shares), amounting to ₹10,10,174.
The issue includes a reservation of up to 70,237 shares for employees offered at a discount of ₹119.00 to the issue price.
ICICI Securities Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Entero Healthcare Solutions IPO RHP for detailed Information.
| IPO Date | February 9, 2024 to February 13, 2024 |
| Listing Date | February 16, 2024 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹1195 to ₹1258 per share |
| Issue Price Final | ₹1258 per share |
| Lot Size | 11 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 1,27,20,044 shares (aggregating up to ₹1,600.00 Cr) |
| Fresh Issue | 79,52,518 shares (aggregating up to ₹1,000.31 Cr) |
| Offer for Sale | 47,67,526 shares of ₹10 (aggregating up to ₹599.69 Cr) |
| Employee Discount | ₹119.00 |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 3,95,77,705 shares |
| Share Holding Post Issue | 4,75,26,830 shares |
Entero Healthcare Solutions IPO offers total 1,27,25,244 shares. Out of which 94,91,256 (74.59%) allocated to QIB, 37,96,503 (29.83%) allocated to QIB, 18,98,251 (14.92%) allocated to NII, 12,65,500 (9.94%) allocated to RII and 56,94,753 (44.75%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 94,91,256 (74.59%) | NA |
| − Anchor Investor Shares Offered | 56,94,753 (44.75%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 37,96,503 (29.83%) | NA |
| NII (HNI) Shares Offered | 18,98,251 (14.92%) | NA |
| − bNII > ₹10L | 12,65,500 (9.94%) | 7,669 |
| − sNII < ₹10L | 6,32,751 (4.97%) | 3,834 |
| Retail Shares Offered | 12,65,500 (9.94%) | 1,15,045 |
| Employee Shares Offered | 70,237 (0.55%) | NA |
| Total Shares Offered | 1,27,25,244 (100.00%) |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Entero Healthcare Solutions IPO raises ₹716.40 crore from anchor investors. Entero Healthcare Solutions IPO Anchor bid date is February 8, 2024. Entero Healthcare Solutions IPO Anchor Investors list
| Bid Date | February 8, 2024 |
| Shares Offered | 56,94,753 |
| Anchor Portion Size (In Cr.) | 716.40 |
| Anchor lock-in period end date for 50% shares (30 Days) | March 15, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | May 14, 2024 |
Entero Healthcare Solutions IPO opens on February 9, 2024, and closes on February 13, 2024.
| IPO Open Date | Fri, Feb 9, 2024 |
| IPO Close Date | Tue, Feb 13, 2024 |
| Tentative Allotment | Wed, Feb 14, 2024 |
| Initiation of Refunds | Thu, Feb 15, 2024 |
| Credit of Shares to Demat | Thu, Feb 15, 2024 |
| Tentative Listing Date | Fri, Feb 16, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on Tue, Feb 13, 2024 |
Investors can bid for a minimum of 11 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 11 | ₹13,838 |
| Retail (Max) | 14 | 154 | ₹1,93,732 |
| S-HNI (Min) | 15 | 165 | ₹2,07,570 |
| S-HNI (Max) | 72 | 792 | ₹9,96,336 |
| B-HNI (Min) | 73 | 803 | ₹10,10,174 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
During the fiscal years 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail customers, respectively. Additionally, they also served over 1,600, 2,500, and 3,400 hospital customers during the same period.
Entero Healthcare Solutions has relationships with over 1,900 healthcare product manufacturers, giving them access to over 64,500 product stock-keeping units as of March 31, 2023.
The company has 73 warehouses in 37 cities across 19 states and union territories, and its customer base includes over 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This provides excellent access to healthcare product manufacturers.
As of 31st March, 2023, the company employs a total of 3014 people in various departments.
Entero Healthcare Solutions Limited's revenue increased by 30.84% and profit after tax (PAT) rose by 62.28% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 1,505.95 | 1,308.73 | 1,125.98 | 833.79 |
| Total Income | 1,898.98 | 3,305.72 | 2,526.55 | 1,783.67 |
| Profit After Tax | 11.64 | -11.10 | -29.44 | -15.35 |
| Net Worth | 660.54 | 597.66 | 563.22 | 487.06 |
| Total Borrowing | 488.68 | 373.52 | 285.03 | 141.70 |
| Amount in ₹ Crore | ||||
The market capitalization of Entero Healthcare Solutions IPO is ₹3021.21 Cr.
| KPI | Values |
|---|---|
| ROE | -2.66% |
| ROCE | 6.06% |
| Debt/Equity | 0.45 |
| RoNW | -1.86% |
| Price to Book Value | 7.22 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 0.00 | 9.70 |
| P/E (x) | 0 | 129.75 |
The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
[Dilip Davda] The company is one of the leading and fastest growing healthcare product distributor in India. EHSL marked losses for FY21 to FY23 and turned the corner for H1 of FY24. Based on annualized FY24 earnings, the issue appears aggressively priced, discounting all near term positives. Well-informed/risk seeker/cash surplus investors may park funds for the long term reward as it holds prospects going forward. Read detail review...
| Listing Date | February 16, 2024 |
| BSE Script Code | 544122 |
| NSE Symbol | ENTERO |
| ISIN | INE010601016 |
| Final Issue Price | ₹1258 per share |
| BSE Listing Group | B |
Entero Healthcare Solutions Ltd.
Plot No. I-35, Building - B
Industrial Area Phase - I
13/7 Mathura Road, Faridabad 121 003
Faridabad, Haryana
Phone: +91 22-69019100
Email: jayant.prakash@enterohealthcare.com
Website: https://www.enterohealthcare.com/
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: enterohealthcare.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Entero Healthcare Solutions IPO is a main-board IPO of 1,27,20,044 equity shares of the face value of ₹10 aggregating up to ₹1,600.00 Crores. The issue is priced at ₹1258 per share. The minimum order quantity is 11.
The IPO opens on February 9, 2024, and closes on February 13, 2024.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Entero Healthcare Solutions IPO using UPI as a payment gateway. Zerodha customers can apply in Entero Healthcare Solutions IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Entero Healthcare Solutions IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Entero Healthcare Solutions IPO opens on February 9, 2024 and closes on February 13, 2024.
Entero Healthcare Solutions IPO lot size is 11, and the minimum amount required for application is ₹13,838.
You can apply in Entero Healthcare Solutions IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Entero Healthcare Solutions IPO will be done on Wednesday, February 14, 2024, and the allotted shares will be credited to your demat account by Thursday, February 15, 2024. Check the Entero Healthcare Solutions IPO allotment status.
The Entero Healthcare Solutions IPO listing date is on Friday, February 16, 2024.
Useful Articles
RHP